SCHEMBL5090836

SCHEMBL5090836

C[Si](C)(CNC(=O)CCS)c1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.41
HPGD P15428 4/20 0.40
HTT P42858 1/20 0.39
HDAC6 Q9UBN7 7/20 0.37
HDAC3 O15379 3/20 0.34
HDAC4 P56524 3/20 0.34
HDAC1 Q13547 3/20 0.34
HDAC7 Q8WUI4 3/20 0.34
HDAC2 Q92769 3/20 0.34
HDAC10 Q969S8 3/20 0.34
HDAC11 Q96DB2 3/20 0.34
HDAC8 Q9BY41 3/20 0.34
HDAC9 Q9UKV0 3/20 0.34
HDAC5 Q9UQL6 3/20 0.34
KMT2A Q03164 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5097544 0.87 HPGD (0.46) LMNAHPGDHTTHDAC6HDAC3
SCHEMBL5085616 0.85 HPGD (0.40) HPGDHTTHDAC6HDAC3HDAC4
SCHEMBL4401368 0.72 KDM4E (0.40) HDAC6CA1CA2CA9
SCHEMBL4401363 0.72 KDM4E (0.40) HDAC6CA1CA2CA9
SCHEMBL5090684 0.72 ALDH1A1 (0.39) LMNAHPGDHTTHDAC6HDAC3
SCHEMBL5139867 0.71 HDAC3 (0.50) HPGDHDAC6HDAC3HDAC4HDAC1
SCHEMBL5806467 0.68 HDAC3 (0.62) LMNAHDAC6HDAC3HDAC4HDAC1
SCHEMBL5138320 0.65 FAAH (0.34) LMNAHDAC6HDAC3HDAC4HDAC1
SCHEMBL5095946 0.65 HTT (0.47) HTT
SCHEMBL5087320 0.64 FAAH (0.41) HDAC6HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1968609-A2 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF HIGHLY LIPOPHILIC SULFHYDRYL COMPOUNDS RND Pharmaceuticals, Inc. (US) 2008-09-17 EP disclosed
WO-2007073560-A2 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF HIGHLY LIPOPHILIC SULFHYDRYL COMPOUNDS RND PHARMACEUTICALS, INC. (US) 2007-06-28 WO disclosed